Can HER2-Positive Breast Cancer treatment cause heart problems years later

Heart Problems from HER2-Positive Breast Cancer Treatment: What You Need to Know

Yes, HER2-positive breast cancer treatments can cause heart problems, and importantly, these problems can develop years after treatment ends. This is a well-documented concern that your care team should be monitoring.

How HER2 Treatments Affect the Heart

Trastuzumab (Herceptin) and Heart Risk

According to cardio-oncology expert Dr. [removed] Moslehi from UCSF, trastuzumab—the primary HER2-targeted antibody therapy—can cause heart failure, similar to older chemotherapy drugs. When trastuzumab was approved over 20 years ago, doctors discovered an unexpected problem: the drug causes heart problems even though it's a targeted therapy designed to be more specific than traditional chemotherapy.

Because of this discovery, the NCCN (National Comprehensive Cancer Network) now requires that every patient receiving Herceptin gets echocardiogram monitoring during treatment to check heart function.

The Timeline: Why "Years Later" Matters

Heart damage from cancer treatments can follow two patterns:

1. During treatment: Some heart problems develop while you're actively receiving therapy
2. Delayed effects: Heart problems can appear months or even years after treatment ends

This delayed pattern was first observed in pediatric cancer survivors who received older chemotherapy drugs (anthracyclines). Children would do well initially, grow up to be 20-25 years old, and then develop heart disease—which was completely unexpected at the time.

Key Risk Factors for Heart Problems

According to NCCN guidelines, your risk depends on several factors:

• Age: Both very young and older patients face higher risk
• Underlying heart disease: If you already have heart problems, your risk increases significantly
• Cumulative dose: The total amount of HER2-targeted therapy matters
• Other treatments: Combining Herceptin with certain chemotherapy drugs (like anthracyclines/doxorubicin) increases risk
• Radiation to the chest: If you received chest radiation, this adds additional cardiac risk

What Heart Problems Can Develop?

Common cardiac side effects include:

• Cardiomyopathy (weakened heart muscle that doesn't pump effectively)
• Heart failure (the heart can't pump enough blood)
• Decreased heart function (measured by ejection fraction on echocardiograms)
• Arrhythmias (irregular heartbeat)

Research shows that approximately 7-10% of breast cancer patients treated with certain chemotherapy combinations develop cardiomyopathy after treatment completion.

Monitoring and Prevention

The NCCN now recommends the ABCDE approach to cardiovascular wellness for cancer survivors:

• Assess your cardiac risk factors
• Blood pressure management
• Cholesterol control
• Diabetes prevention/management
• Exercise and healthy lifestyle

Specific monitoring recommendations:

• Echocardiograms during and after treatment
• EKG (heart rhythm) testing
• Regular blood pressure checks
• Monitoring for symptoms like shortness of breath, chest pain, or swelling

Symptoms to Watch For

Contact your doctor if you experience:

• Shortness of breath (especially with activity)
• Chest pain or discomfort
• Irregular heartbeat or palpitations
• Swelling in legs or feet
• Unusual fatigue or weakness
• Dizziness or lightheadedness

Questions to Ask Your Oncology Team

Since your situation is specific to YOUR case, ask your doctors:

1. What is my baseline heart function? (Ask for your ejection fraction number from your echocardiogram)
2. How often should I have cardiac monitoring during and after treatment? (This should be part of your treatment plan)
3. Are there any medications I should take to protect my heart during treatment? (Some patients benefit from heart-protective drugs)
4. What lifestyle changes can I make to reduce cardiac risk? (Exercise, diet, weight management, smoking cessation)
5. If I develop heart problems, what treatment options exist? (Many heart problems from cancer treatment are manageable if caught early)

The Bottom Line

Heart problems from HER2-targeted therapy are a real but manageable risk. The key is:

• Baseline testing before treatment starts
• Regular monitoring during and after treatment
• Early detection of any changes in heart function
• Proactive management of risk factors like blood pressure and cholesterol

According to NCCN Guidelines and cardio-oncology research, patients who receive appropriate cardiac monitoring and management have much better outcomes. Your oncologist should be coordinating with a cardiologist or monitoring your heart function regularly.

---

Sources:

• NCCN Guidelines (referenced by Dr. [removed] Moslehi, UCSF Cardio-Oncology)
• "Cardio-Oncology: A New Clinical Frontier" - Dr. [removed] Moslehi, UCSF
• American Cancer Society recommendations on cancer treatment side effects

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.